Role of Topical Application of Fosfomycin in Treatment of Chronic Suppurative Otitis Media
DOI:
https://doi.org/10.36570/jduhs.2018.3.598Keywords:
Topical fosfomycin, Ear drops, Chronic suppurative otitis mediaAbstract
Objective: To ind out the eficacy of topical application of 3% Fosfomycin in cases of Chronic Suppurative Otitis Media (CSOM).
Methods: This prospective study was conducted from January 2016 to December 2017 in the Department of ENT, Head & Neck Surgery, Dow University of Health Sciences & Dr. Ruth K.M. Pfau Civil Hospital Karachi, Pakistan. All patients had clinical diagnosis of CSOM. Fosfomycin 3% was given topical treatment in ear drop three times daily for one week. Amount given in each dose was 2 drops or 0.1 ml. A complete audiological assessment was conducted by an audiologist at day 7 and outcome of the treatment was noted as resolved (complete dry ear), Improved, Not-changed or Worsened.
Results: Out of 172 patients, 65 (37.8%) had pseudomonas Aeroginosa, 49 (28.5%) had Staphylococcus Aureus, 37 (21.5%) had Proteus Mirabilis, 6 (3.5%) had E Coli, 6 (3.5%) had Klebsiella Pneumoniae, 4 (2.3%) had Enterobacter species whereas 5 (2.9%) patients had miscellaneous organisms on culture of ear swab. The mean duration of discharge was 7.23 ±5.78 years. The outcome showed that majority of the patients 144 (83.7%) had completely dry ear after one week of treatment with 3% fosfomycin. Other 17 patients (9.9%) had improvement with decrease in amount of ear discharge. Nine patients (5.2%) had no change in ear discharge and in 2 cases (1.2%) amount of ear discharge increased.
Conclusion: The inding of this study depicted that topical application of 3% fosfomycin can be very beneicial in cases of CSOM. Overall response to treatment was good and no otoxicity was noted.
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Articles published in the Journal of Dow University of Health Sciences are distributed under the terms of the Creative Commons Attribution Non-Commercial License https://creativecommons.org/ licenses/by-nc/4.0/. This license permits use, distribution and reproduction in any medium; provided the original work is properly cited and initial publication in this journal.